The challenge of recurrent hepatitis C virus in liver transplant recipients

Area of Science:

• Hepatology
• Transplantation Medicine
• Virology

Background:

• Hepatitis C virus (HCV) is the primary indication for liver transplantation (LT) globally.
• Short-term survival post-LT for HCV is comparable to other indications.
• A concerning trend of reduced long-term survival in LT recipients with HCV is observed.

Purpose of the Study:

• To review the evolving natural history of HCV infection after LT.
• To discuss the challenges faced by LT recipients with HCV.
• To highlight concerns regarding the increasing aggressiveness of recurrent HCV disease.

Main Methods:

• Literature review of studies on HCV recurrence post-LT.
• Analysis of factors influencing HCV recurrence and disease progression.
• Evaluation of antiviral therapies and retransplantation in HCV-LT patients.

Main Results:

• HCV recurrence post-LT is common, with a spectrum from mild to aggressive fibrosing cholestatic hepatitis.
• Recurrent HCV infection is increasingly aggressive, though causes are not fully understood.
• Interferon-based therapies show some efficacy but have significant toxicity; pegylated interferons offer better response rates.

Conclusions:

• Managing HCV in LT recipients presents unique and evolving challenges.
• Aggressive recurrence of HCV post-LT impacts long-term graft and patient survival.
• Further research is needed to elucidate causes of aggressive recurrence and optimize treatment strategies.